Background and aim: Several measures have been developed to assess the health-related quality of life [HRQoL] of patients with inflammatory bowel disease [IBD]. Our aim is to systematically review the HRQoL measures specific for patients with IBD and to appraise their measurement properties and methodological quality. Methods: We searched the PubMed, Embase, and PsycINFO databases for original articles describing the development and/or evaluation of one or more of the measurement properties [e.g. internal consistency, reliability, validity, responsiveness] of HRQoL measures specific for IBD. We assessed the measurement properties and examined the methodological quality of the measurement properties of each instrument using a standardized checklist. Results: We examined the full text of 75 articles that we deemed potentially eligible and identified 10 disease-specific HRQoL measures in IBD that covered different aspects of patients' lives. Internal consistency, construct validity, and content validity were the commonly evaluated measurement properties. Seven HRQoL measures scored positive for at least four of eight measurement properties. The majority of studies were rated as 'fair' to 'poor' when assessing their methodology quality. The most established HRQoL measure in the literature was the Inflammatory Bowel Disease Questionnaire [IBDQ]. Conclusions: Most of the included HRQoL measures did not include all the required measurement properties or had a problem with their methodological quality. The most widely used and validated measure was the IBDQ. Further validation studies are required to support the use of other HRQoL measures.
Introduction
Inflammatory bowel disease [IBD] is known to impair quality of life [1] [2] [3] [4] and cause a substantial burden to patients, their families, and society. [4] [5] [6] [7] It affects patients' lives mentally, emotionally, socially, and physically.
In the past two decades, measurement of HRQoL has been increasingly used in IBD to support both research and clinical care. 1, [13] [14] [15] [16] [17] [18] [19] This has led to a better evaluation of patients' health and subsequently to improvements in their quality of care. 15, 16 In scientific research, these measures are important to evaluate the effectiveness of new therapies in clinical trials. An up-to-date systematic review will provide a useful resource for research professionals and IBD specialists to ensure they can select an appropriate HRQoL measure for patients in their practice.
The aim of this article is to systematically review the current HRQoL measures specific for patients with IBD and to appraise their measurement properties using a robust evaluation methodology checklist.
Selection criteria
We included all original articles in English describing the development and/or evaluation of one or more of the measurement properties [e.g. internal consistency, reliability, validity, responsiveness] of the HRQoL measures specific for patients with IBD. Articles were included if they sought to assess at least one domain of quality of life in IBD.
Two reviewers [LA and IR] independently screened titles, abstracts and the references of these articles to obtain any additional articles of relevance. Full texts of eligible articles were obtained. If any disagreement existed regarding the inclusion or exclusion of articles, a third independent reviewer was consulted.
Data extraction
Data from eligible articles were extracted independently using a pre-prepared data extraction proforma. The following data were extracted: 23, 24 The COSMIN checklist assesses the methodology quality of the internal consistency, reliability, measurement error, responsiveness, content validity, construct validity, and factor analysis [structural validity]. Each measurement property methodology was assessed against certain quality standards and rated on a 4-point scale [1 = poor, 2 = fair, 3 = good, or 4 = excellent]. The overall score for the methodological quality of a certain property is determined by taking the lowest rating. Depending on the number of measurement properties assessed in a study, some studies received one quality evaluation whereas other studies received several. The measurement property of a study was rated as having 'excellent' quality if all relevant COSMIN items were scored adequate. 4. Levels of the HRQoL measure establishment or use in literature: we used Cohen's criteria 25 [ Table 2 ] to determine the level of establishment of each specific HRQoL measure. The Cohen criteria classify the measures into three levels of establishment depending on the number of publications, the extent to which the measures are described in literature, and their psychometric properties.
Results

Results of the database search and included studies:
The database search resulted in 437 articles [ Figure 1 ]. References were uploaded into EndNote and duplicates were removed, leaving 389 articles. After screening the titles and abstracts, 196 articles were excluded because they did not include validation of the HRQoL, and 10 articles were excluded because they were published as abstracts in conferences and not as full papers. The full texts of 183 articles were obtained and reviewed. We excluded 108 articles that did not include the validation or evaluation of the psychometric properties of the HRQoL measures; 75 articles were deemed eligible. After linking multiple reports of the same HRQoL measure, we identified 10 disease-specific HRQoL measures in IBD [ 29 When evaluating the measurement properties for the rest of the HRQoL measures using the Terwee's criteria, none has met all the criteria. Flooring and ceiling effects were not clearly reported when validating most of the HRQoL measures. When appraising the internal consistency of each measure, eight measures achieved the recommended Cronbach α value of 0.70.9 22 [ Table 1 ]. Two measures did not have their internal consistency assessment reported in the literature. Ratings of the content validity were good for most of the measures, as they used appropriate methods in generating items that covered various quality of life aspects of IBD [e.g. focus group, patient involvement, item generation and selection, measure reduction, etc.]. CD burden measure did not use an appropriate method to generate the items. Construct validity was appropriately assessed in almost all measures except the IBD disability index, which was not fully validated. The HRQoL measures were compared with other measures of disease severity or quality of life. Six HRQoL measures correctly assessed the test-retest reliability and achieved the required values of the intraclass correlation coefficient, Kappa coefficients, or confidence intervals. Most of the measures did not assess the interrater reliability as part of the reliability testing. Three HRQoL measures had their responsiveness assessed in the original study report using the required statistics such as responsiveness ratio or paired t-tests. Seven measures did not have their responsiveness reported in literature. Measurement error evaluation and factor analysis were not assessed for most of the HRQoL measures.
Assessing the methodology qualities of the HRQoL measures
None of the HRQoL measures development studies showed adequate methodological quality in all COSMIN sections. Most of the publications scored excellent for content validity, having captured the domains that are relevant to IBD patients through consultation with patients and/or or literature review or other methods as described by Steiner and Norman. 52 Although all HRQoL measures assessed the construct validity using other measures of HRQoL or disease activity, more than half of the measures scored 'fair' either because they did not provide information on the missing items, a hypothesis regarding the direction and magnitude of correlations, or sample size, or did not achieve the required statistics. Most HRQoL measures were assessed for reliability, internal consistency, and responsiveness. However, for most of them, this was not described in enough detail to meet the COSMIN criteria. Most of the publications did not report how missing items were handled nor how repeated measurements were conducted [mode of administration, sample size, statistical analyses, and time interval for test-retest]. Most of the studies did not include the assessment of measurement error or factor analysis in the measure development and were rated 'poor' for these criteria. Table 5 shows the COMSIN ratings for the IBD-specific HRQoL measures.
Assessing the level of credibility of the HRQoL measures:
We used Cohen's criteria 25 to appraise the degree establishment of the different HRQoL measures in IBD. According to Cohen's criteria, only the IBDQ and SIBDQ were considered to be well-established measures, and the RFIC was approaching the level of well-established assessments. The rest were rated as promising assessments [ Table 6 ].
Discussion
Assessing the HRQoL in patients with IBD is an important outcome measure in assessing the efficacy of new treatments or interventions. Typically, HRQoL measures have been developed and used to describe mean scores [or mean response] for a group of patients [e.g. those in each arm of a trial]. The past decade has seen a rapid increase in the number of measures to assess HRQoL in patients with IBD. [32] [33] [34] [35] [36] [53] [54] [55] [56] [57] In this systematic review we identified 10 different HRQoLspecific measures used for patients with IBD. We assessed the internal consistency, reliability, measurement error, content validity, factor analysis, construct validity, responsiveness, and ceiling and flooring effects, depending on the information obtained from the literature. Some of the HRQoL measures had some aspects of psychometric strength, especially construct validity. However, they varied greatly in terms of their characteristics and most of them did not demonstrate all the properties proposed by Terwee et al. 22 Notably the IBDQ, 26, 27 which is the most commonly used HRQoL measure in the literature, was not fully validated in the original study. However, it was further validated in subsequent studies that used it or translated it into other languages. The IBDQ has the advantage of having shorter versions [SIBDQ 28 and IBDQ-9 29 ] and has been translated into different languages, which facilitates its use worldwide.
We used the COSMIN checklist 23, 24 to appraise the methodological quality of the original HRQoL measures development studies. This included evaluation of the methodological quality of different properties such as the reliability, internal consistency, content validity, structural validity [factor analysis], responsiveness, measurement error, and construct validity. Using the COSMIN criteria of the methodology quality, the majority of studies were rated as 'fair' to 'poor' either because they did not reach the required standards or because of insufficient information. These studies are not necessarily of poor quality, but our results suggest that high quality studies are required to properly evaluate their measurement properties.
We also assessed the level of establishment of the HRQoL measures using the Crohn's criteria. 25 We found that the IBDQ and SIBDQ were considered to be well-established measures, and the RFIC is approaching the level of being well-established. The rest were rated as promising assessments.
We used a robust quality criterion 22 to systematically evaluate the psychometric properties of the identified HRQoL measures. We also used the COSMIN checklist 23 to assess the methodological quality of the properties of the HRQoL measures in IBD. These criteria are increasingly used in systematic reviews of outcome measures. [58] [59] [60] [61] [62] [63] The content validity, reliability, and validity of the COSMIN standards checklist were showed to be valid and reliable. 64 However, a limitation of the COSMIN checklist and the quality properties of outcome measures [22] [23] [24] is that they were recently developed and might not be applicable to measures developed before its introduction. The inconsistency in the measurement properties may be explained by the fact that there was no agreement on a definition of the required measurement properties until recently. However, questionnaires still need to meet validity and reliability criteria and be described in a comprehensive manner. Studies included in the systematic review were judged to be of poor methodological quality when evaluated by the COSMIN checklist if they were not descriptive enough to reach the COSMIN pre-defined standards. Especially when it comes to missing items, if not clearly described, then most properties will be rated fair even if they were undertaken properly in the study. Most of the HRQoL have been recently developed and their validation is still ongoing. Hence, future studies are likely to provide additional evidence to support their validity and reliability.
Although the COSMIN checklist and the quality criteria for the measurement properties were designed to be as objective as possible, reviewers' judgments can be different. Therefore, two reviewers evaluated the included studies and a third reviewer was consulted in case of disagreement.
We limited our search to English language studies because of the limited translation facilities available to us. Therefore, we might have missed HRQoL measures that were developed in other languages. However, our extensive and systematic search included studies that were carried out in non-English speaking countries but written in English. We did not find any mention of a non-English HRQoL measure specifically developed for IBD. Previous reviews of HRQoL measures in patients with IBD have limited their search to only a single concept of multi-dimensional HRQoL and included a limited number of measures. 1, [65] [66] [67] [68] There is no review in the literature that has evaluated the methodological quality of the measurement properties of the included HRQoL measures. One of the strengths of this systematic review is that it did not only focus on the single concept of multi-dimensional HRQoL, but also took into account related concepts such as disease burden, work productivity, fatigue, and social impact. We performed the literature search in a systematic way to identify all HRQoL measures used in IBD.
To our knowledge, this is the first systematic review of HRQoL measures in IBD that systematically appraised the measurement properties and the methodological quality of the HRQoL measures using a robust and standardized approach. This facilitates good comparison between the HRQoL measures on the quality of their measurement properties. This review will better guide the use of HRQoL in various clinical and research settings. It will also help clinicians, researchers, and the general public to better assess the scientific literature on HRQoL in IBD. Several new HRQoL measures are emerging, and our study showed that most of the HRQoL are supported by evidence of at least one type of reliability or validity and further validation studies might support their use. The choice of HRQoL measure in future will depend on the context for which it will be used [for example, social, disease burden, disability, etc.]. Until then, the IBDQ 26, 27 has the strongest published evidence of reliability and validity and it is well established in the literature.
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